KRKA - Start of buy-back programme

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 30 / 2017

Date of issue: 2017-07-28

Short name of the issuer

KRKA

Subject

Start of buy-back programme

Official market - legal basis

Unofficial market - legal basis

Contents of the report:

On 6 July 2017 the 23rd Annual General Meeting authorized the Management Board for the acquisition of treasury shares in accordance with the Article 247 of the Companies Act. The company is disclosing that it will commence with the acquisition of treasury shares in accordance with this authorization under following conditions: The maximum pecuniary amount allocated to the programme is EUR 227,820,770. The maximum number of shares to be acquired is 2,720,248. Duration of the programme is 36 months from the date of the General Meeting authorization. Shares will be acquired on the regulated market at the respective market price and under the terms, that will not have an influence on the prevailing market conditions. The public will be regularly informed about these acquisitions of treasury shares. The company may dispose the treasury shares acquired under this authorisation in exchange for equity-stakes in other companies by pursuing its M&A strategy, or by selling them to a strategic partner.

Annexes

File Description

KRKA, TOVARNA ZDRAVIL D.D.

(fullname of the issuer)

KRKA Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

8501 Nove Mesto

(post code) (city)

Smarjeska 6

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nie dotyczy

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2017-07-28 Jože Colarič President of the Management Board